⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1701005 | 0.86 | CA2 (0.45) | — | |
| SCHEMBL19976382 | 0.82 | GPR84 (0.55) | — | |
| SCHEMBL20451492 | 0.82 | GPR84 (0.55) | — | |
| SCHEMBL3130179 | 0.80 | — | — | |
| SCHEMBL851277 | 0.79 | — | — | |
| SCHEMBL867273 | 0.78 | — | — | |
| SCHEMBL8779996 | 0.77 | — | — | |
| SCHEMBL5133204 | 0.77 | TAS1R3 (0.50) | — | |
| SCHEMBL825585 | 0.76 | HDAC7 (0.41) | — | |
| SCHEMBL8620608 | 0.76 | HDAC8 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432811-B1 | CURABLE COATING COMPOSITION CONTAINING A COMPOUND HAVING A URETDIONE GROUP AND A DIFFERENT FUNCTIONAL GROUP AND CURED COATINGS | BASF COATINGS GMBH (DE) | 2016-03-23 | — | — | EP | disclosed |
| US-8629231-B2 | Methods of making oligomers, coating compositions containing them, and coated articles | BASF COATINGS GMBH (DE) | 2014-01-14 | — | — | US | disclosed |
| US-8487108-B2 | Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors | VITAE PHARMACEUTICALS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-8455497-B2 | Inhibitors of aspartyl protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-06-04 | — | — | US | disclosed |
| EP-2432844-B1 | OLIGOMERS HAVING URETDIONE STRUCTURE, METHODS OF MAKING THEM, COATING COMPOSITIONS CONTAINING THEM, AND CURED COATINGS THEREOF | BASF COATINGS GMBH (DE) | 2013-03-20 | — | — | EP | disclosed |
| US-8293836-B2 | Curable coating composition containing a compound having a uretdione group and a different functional group and cured coatings | BASF COATINGS GMBH (DE) | 2012-10-23 | — | — | US | disclosed |
| EP-2432811-A1 | CURABLE COATING COMPOSITION CONTAINING A COMPOUND HAVING A URETDIONE GROUP AND A DIFFERENT FUNCTIONAL GROUP AND CURED COATINGS | BASF Coatings GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| EP-2432844-A1 | OLIGOMERS HAVING URETDIONE STRUCTURE, METHODS OF MAKING THEM, COATING COMPOSITIONS CONTAINING THEM, AND CURED COATINGS THEREOF | BASF Coatings GmbH (DE) | 2012-03-28 | — | — | EP | disclosed |
| US-7875693-B2 | reacting hexamethylene diisocyanate with aminopropy/ltrimethoxysilane/3-/ to form intermediate isocyanatoalkylsilane and reacting the isocyanatoalkylsilane with an isocyanate to form a biuret | PERSTORP FRANCE (FR) | 2011-01-25 | — | — | US | disclosed |
| US-20100298490-A1 | OLIGOMERS, METHODS OF MAKING THEM, COATING COMPOSITIONS CONTAINING THEM, AND CURED COATINGS | BASF CORPORATION (US) | 2010-11-25 | — | — | US | disclosed |
| US-20100179109-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2010-07-15 | — | — | US | disclosed |
| US-20100130471-A1 | Renin Inhibitors | SMITHKLINE BEECHAM CORPORATION | 2010-05-27 | — | — | US | disclosed |
| US-20100048636-A1 | Aspartic Protease Inhibitors | VITAE PHARMACEUTICALS, INC. | 2010-02-25 | — | — | US | disclosed |
| US-20090275581-A1 | RENIN INHIBITORS | VITAE PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090274650-A1 | INHIBITORS OF ASPARTYL PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED | 2009-11-05 | — | — | US | disclosed |
| US-20090264428-A1 | Renin Inhibitors | VITAE PHARMACEUTICALS, INC. | 2009-10-22 | — | — | US | disclosed |
| US-20090186884-A1 | such as N-(3-amino-2-hydroxypropyl)-3-(1-(2-(2-ethylphenoxy)phenyl)-1-hydroxy-5-;methoxypentyl)piperidine-1-carboxamide, used for the treatment of cardiovascular disorders | VITAE PHARMACEUTICALS, INC. | 2009-07-23 | — | — | US | disclosed |
| WO-2008124575-A1 | RENIN INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2008124582-A1 | RENIN INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| US-4331438-A | TREATMENT WITH A FORMALDEHYDE ACCEPTOR | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |